Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam P Silverman

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2010
Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrinLei Jiang, Richard H Kimura, Zheng Miao, et al.
Science Translational Medicine|February 18, 2021
APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular functionMonica Xiong, Hong Jiang, Javier Remolina Serrano, et al.
The CRISPR Journal|September 23, 2024
Identification of a Guide RNA Targeting an Ultraconserved Element for Evaluation of Cas9 Genome Editors Across Mammalian SpeciesBenjamin G Gowen, Prachi Khekare, Shannon R McCawley, et al.
Molecular Genetics and Metabolism|July 18, 2023
An orally administered enzyme therapeutic for homocystinuria that suppresses homocysteine by metabolizing methionine in the gastrointestinal tractKristen Skvorak, Vesna Mitchell, Leann Teadt, et al.
Scientific Reports|March 24, 2023
Optimizing human α-galactosidase for treatment of Fabry diseaseWilliam C Hallows, Kristen Skvorak, Nick Agard, et al.
Journal of Inherited Metabolic Disease|July 26, 2023
Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primatesKristen Skvorak, Joyce Liu, Nikki Kruse, et al.
Plos One|June 24, 2025
Evaluation of subretinally delivered Cas9 ribonucleoproteins in murine and porcine animal models highlights key considerations for therapeutic translation of genetic medicinesSpencer C Wei, Aaron J Cantor, Jack Walleshauser, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Evaluation of subretinally delivered Cas9 ribonucleoproteins in murine and porcine animal models highlights key considerations for therapeutic translation of genetic medicinesSpencer C Wei, Aaron J Cantor, Jack Walleshauser, et al.
The Journal of Clinical Investigation|March 31, 2018
Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulationFan Liao, Aimin Li, Monica Xiong, et al.
Science Translational Medicine|May 29, 2020
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeysMihalis S Kariolis, Robert C Wells, Jennifer A Getz, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2010
Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrinLei Jiang, Richard H Kimura, Zheng Miao, et al.
Science Translational Medicine|February 18, 2021
APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular functionMonica Xiong, Hong Jiang, Javier Remolina Serrano, et al.
The CRISPR Journal|September 23, 2024
Identification of a Guide RNA Targeting an Ultraconserved Element for Evaluation of Cas9 Genome Editors Across Mammalian SpeciesBenjamin G Gowen, Prachi Khekare, Shannon R McCawley, et al.
Molecular Genetics and Metabolism|July 18, 2023
An orally administered enzyme therapeutic for homocystinuria that suppresses homocysteine by metabolizing methionine in the gastrointestinal tractKristen Skvorak, Vesna Mitchell, Leann Teadt, et al.
Scientific Reports|March 24, 2023
Optimizing human α-galactosidase for treatment of Fabry diseaseWilliam C Hallows, Kristen Skvorak, Nick Agard, et al.
Journal of Inherited Metabolic Disease|July 26, 2023
Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primatesKristen Skvorak, Joyce Liu, Nikki Kruse, et al.
Plos One|June 24, 2025
Evaluation of subretinally delivered Cas9 ribonucleoproteins in murine and porcine animal models highlights key considerations for therapeutic translation of genetic medicinesSpencer C Wei, Aaron J Cantor, Jack Walleshauser, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Evaluation of subretinally delivered Cas9 ribonucleoproteins in murine and porcine animal models highlights key considerations for therapeutic translation of genetic medicinesSpencer C Wei, Aaron J Cantor, Jack Walleshauser, et al.
The Journal of Clinical Investigation|March 31, 2018
Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulationFan Liao, Aimin Li, Monica Xiong, et al.
Science Translational Medicine|May 29, 2020
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeysMihalis S Kariolis, Robert C Wells, Jennifer A Getz, et al.
Pageof 4